SCHEMBL27612934

SCHEMBL27612934

O/C=C(\F)Cc1cccc2cccnc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.44
TSHR P16473 2/20 0.44
CHRM1 P11229 1/20 0.44
COMT P21964 1/20 0.44
ADRA1A P35348 1/20 0.44
METAP2 P50579 1/20 0.44
METAP1 P53582 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
ALDH1A1 P00352 3/20 0.43
LMNA P02545 2/20 0.43
KDM4E B2RXH2 4/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 2/20 0.42
GMNN O75496 1/20 0.42
TP53 P04637 1/20 0.42
HSP90AA1 P07900 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MMP9 P14780 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27612792 0.77 KDM4E (0.42) ALDH1A1LMNAKDM4EMAPTHTT
SCHEMBL12899533 0.76 PARP1 (0.51) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL9268910 0.75 MMP2 (0.48) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL19036261 0.75 HDAC6 (0.50) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL30553881 0.75 KDM4E (0.59) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL3711541 0.75 KDM4E (0.59) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL6189901 0.73 PARP1 (0.49) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL9268906 0.73 HDAC6 (0.49) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL9181528 0.73 PARP1 (0.57) MMP2TSHRCHRM1COMTADRA1A
SCHEMBL28848125 0.73 KDM4E (0.54) MMP2TSHRCHRM1COMTADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1585775-A 6-O-acyl ketolide derivatives of erythromycine useful as antibacterials ORTHO MCNEIL PHARM INC (US) 2005-02-23 CN disclosed